Joan A. Barbera
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Joan A.
Contact Joan A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Vascular Obstruction Scoring on Dual-energy CT, Cone-beam CT and Digital Subtraction Angiography: Correlation with Invasive Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension
Original InvestigationArticles in PressOpen access aDepartment of Medical Imaging, University of Toronto, Toronto M5T1W7, ON, Canada (A.P-C.) bDepartment of Radiology, CDI, Hospital Clínic Barcelona, Barcelona 08036, Spain (A.P-C., B.D-X.) cFundació de Recerca Clínic Barcelona, Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain (A.P-C., J.A.B., I.B.) dFaculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona 08036, Spain (A.P-C.,...
Pulmonary hypertension associated with lung diseases
Introduction It has long been known that chronic lung disease (CLD) is frequently complicated by pulmonary hypertension (PH) and right ventricular (RV) dysfunction. Despite this clear association, the prevalence, clinical significance and treatment options for PH in CLD are still under investigation. The heterogeneity of PH in CLD increases the difficulty in characterising this group. In addition, the definitions of PH in general have evolved.
Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry - Respiratory Research
We analyzed patients diagnosed with PAH from the Spanish Registry (REHAP) who initiated treatment with a PDE-5i either in monotherapy or as add-on therapy, between July 2007 and September 2019, were followed-up for at least 12 months, and had sufficient information available to evaluate the response to treatment. One thousand sixty-two patients treated with a PDE-5i were extracted from the REHAP.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Joan A.
Contact Joan A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack